Asia Pacific Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Fusion Biopsy Market would witness market growth of 12.9% CAGR during the forecast period (2020-2026).
Asia Pacific is expected to show fastest growth rate in the forecasted years. The rising awareness among urologists about the functions and features as well as sensitivity and specificity of the targeted MR/Ultrasound biopsy while performing a prostate biopsy is likely to drive the market. Furthermore, the growing private sector participation in healthcare mainly in countries like India, China, and Japan that own high purchasing capabilities are also anticipated to have a positive impact on the fusion biopsy market.
The major companies are emphasizing more on R&D to develop advancement in hardware and software solutions to rationalize the workflow of the targeted MRI/US fusion biopsy. The novel version had an additional accessory of software and hardware to perform a transperineal fusion biopsy. The market players are shifting their attention to various strategies like product launches, collaborations mergers, and acquisitions, strengthening distribution networks, and trying to enter untapped markets, particularly in the developing economies to reinforce their market presence.
Ambulatory care centers are likely to grow at a fast rate in the foreseeable period of time. The increasing occurrence of prostate cancer in rural areas where there is limited access to healthcare service is one of the factors estimated to drive the growth of the market of fusion biopsy. Furthermore, the highly portable and low-cost MRI has been introduced and is anticipated to improve the adoption rate of the targeted MR/Ultrasound biopsy even in the ambulatory care centers, therefore, likely to boost the growth of the overall market.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
Asia Pacific is expected to show fastest growth rate in the forecasted years. The rising awareness among urologists about the functions and features as well as sensitivity and specificity of the targeted MR/Ultrasound biopsy while performing a prostate biopsy is likely to drive the market. Furthermore, the growing private sector participation in healthcare mainly in countries like India, China, and Japan that own high purchasing capabilities are also anticipated to have a positive impact on the fusion biopsy market.
The major companies are emphasizing more on R&D to develop advancement in hardware and software solutions to rationalize the workflow of the targeted MRI/US fusion biopsy. The novel version had an additional accessory of software and hardware to perform a transperineal fusion biopsy. The market players are shifting their attention to various strategies like product launches, collaborations mergers, and acquisitions, strengthening distribution networks, and trying to enter untapped markets, particularly in the developing economies to reinforce their market presence.
Ambulatory care centers are likely to grow at a fast rate in the foreseeable period of time. The increasing occurrence of prostate cancer in rural areas where there is limited access to healthcare service is one of the factors estimated to drive the growth of the market of fusion biopsy. Furthermore, the highly portable and low-cost MRI has been introduced and is anticipated to improve the adoption rate of the targeted MR/Ultrasound biopsy even in the ambulatory care centers, therefore, likely to boost the growth of the overall market.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
- Transperineal
- Transrectal
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Fusion Biopsy Market, by End Use
1.4.2 Asia Pacific Fusion Biopsy Market, by Route
1.4.3 Asia Pacific Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. ASIA PACIFIC FUSION BIOPSY MARKET BY END USES
4.1 Asia Pacific Diagnostic centers Market by Country
4.2 Asia Pacific Hospitals Market by Country
4.3 Asia Pacific Ambulatory care centers Market by Country
CHAPTER 5. ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE
5.1 Asia Pacific Transperineal Market by Country
5.2 Asia Pacific Transrectal Market by Country
CHAPTER 6. ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY
6.1 China Fusion Biopsy Market
6.1.1 China Fusion Biopsy Market by End Uses
6.1.2 China Fusion Biopsy Market by Route
6.2 India Fusion Biopsy Market
6.2.1 India Fusion Biopsy Market by End Uses
6.2.2 India Fusion Biopsy Market by Route
6.3 Japan Fusion Biopsy Market
6.3.1 Japan Fusion Biopsy Market by End Uses
6.3.2 Japan Fusion Biopsy Market by Route
6.4 Australia Fusion Biopsy Market
6.4.1 Australia Fusion Biopsy Market by End Uses
6.4.2 Australia Fusion Biopsy Market by Route
6.5 South Korea Fusion Biopsy Market
6.5.1 South Korea Fusion Biopsy Market by End Uses
6.5.2 South Korea Fusion Biopsy Market by Route
6.6 Singapore Fusion Biopsy Market
6.6.1 Singapore Fusion Biopsy Market by End Uses
6.6.2 Singapore Fusion Biopsy Market by Route
6.7 Rest of Asia Pacific Fusion Biopsy Market
6.7.1 Rest of Asia Pacific Fusion Biopsy Market by End Uses
6.7.2 Rest of Asia Pacific Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Fusion Biopsy Market, by End Use
1.4.2 Asia Pacific Fusion Biopsy Market, by Route
1.4.3 Asia Pacific Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. ASIA PACIFIC FUSION BIOPSY MARKET BY END USES
4.1 Asia Pacific Diagnostic centers Market by Country
4.2 Asia Pacific Hospitals Market by Country
4.3 Asia Pacific Ambulatory care centers Market by Country
CHAPTER 5. ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE
5.1 Asia Pacific Transperineal Market by Country
5.2 Asia Pacific Transrectal Market by Country
CHAPTER 6. ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY
6.1 China Fusion Biopsy Market
6.1.1 China Fusion Biopsy Market by End Uses
6.1.2 China Fusion Biopsy Market by Route
6.2 India Fusion Biopsy Market
6.2.1 India Fusion Biopsy Market by End Uses
6.2.2 India Fusion Biopsy Market by Route
6.3 Japan Fusion Biopsy Market
6.3.1 Japan Fusion Biopsy Market by End Uses
6.3.2 Japan Fusion Biopsy Market by Route
6.4 Australia Fusion Biopsy Market
6.4.1 Australia Fusion Biopsy Market by End Uses
6.4.2 Australia Fusion Biopsy Market by Route
6.5 South Korea Fusion Biopsy Market
6.5.1 South Korea Fusion Biopsy Market by End Uses
6.5.2 South Korea Fusion Biopsy Market by Route
6.6 Singapore Fusion Biopsy Market
6.6.1 Singapore Fusion Biopsy Market by End Uses
6.6.2 Singapore Fusion Biopsy Market by Route
6.7 Rest of Asia Pacific Fusion Biopsy Market
6.7.1 Rest of Asia Pacific Fusion Biopsy Market by End Uses
6.7.2 Rest of Asia Pacific Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 CHINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 CHINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 CHINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 CHINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 CHINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 CHINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 INDIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 INDIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 INDIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 INDIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 INDIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 INDIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 JAPAN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 JAPAN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 JAPAN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 JAPAN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 JAPAN FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 JAPAN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 AUSTRALIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 AUSTRALIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SOUTH KOREA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SOUTH KOREA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 SINGAPORE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 SINGAPORE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
TABLE 1 ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 CHINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 CHINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 CHINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 CHINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 CHINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 CHINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 INDIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 INDIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 INDIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 INDIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 INDIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 INDIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 JAPAN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 JAPAN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 JAPAN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 JAPAN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 JAPAN FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 JAPAN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 AUSTRALIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 AUSTRALIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SOUTH KOREA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SOUTH KOREA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 SINGAPORE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 SINGAPORE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
